Levamlodipine Maleate

马来酸左旋氨氯地平

Report date: 2024/03/25 18:00:07

Base Information

Drug NameLevamlodipine Maleate
Drug Alias Name(S)-(-)-Amlodipine Maleate马来酸左氨氯地平Levoamlodipine Maleate(S)-Amlodipine MaleateS-Amlodipine Maleate +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated L-type calcium channel
Therapy Area/IndicationsHypertensionAngina PectorisRenal Insufficiency, Chronic +[4] 
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryMainland China
Original Approved Date2003/07/24
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCspc Ouyi Pharmaceutical Co LtdOnconetix Inc
Inactive CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsRenal Insufficiency, ChronicHypertension, Renal

Other Information

ATC CodeC08CA01
Related LinksWikipedia